This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

MicroConstants Welcomes Pat DeLisio As Director Of East Coast Business Development

SAN DIEGO, April 2, 2013 /PRNewswire/ -- MicroConstants, a regulated bioanalysis and DMPK specialty Contract Research Organization (CRO) in San Diego, California, announces the appointment of Patricia deLisio as their new director of east coast business development. Pat joins MicroConstants' business development team with more than 12 years of experience selling contract research services to companies in the pharmaceutical, biotech, agrochemical, animal health, and specialty chemical industries. As the director of east coast business development, Pat will be responsible for developing new business opportunities in the region and implementing innovative sales and marketing strategies to help further the company's mission of becoming the recognized leader in bioanalytical and pharmacokinetic analysis.

Prior to joining MicroConstants, Pat held business development and program management positions at several bioanalytical and toxicology CROs throughout the United States. She also spent more than three years as an independent GLP quality assurance consultant. Pat began her career as a research chemist, has spent 11 years as a study director/principal investigator, and has extensive experience in HPLC method development and validation for sample analysis supporting regulated toxicology and metabolism studies. Pat received her bachelor's degree in Chemistry from Notre Dame College in South Euclid, Ohio.

"Pat's extensive knowledge of the pharmaceutical development process and her experience establishing and securing new customer opportunities will be a tremendous asset to MicroConstants' business development team as we focus on enhancing our presence in key geographic regions on the east coast," says Gilbert Lam, president and chief scientific officer at MicroConstants. "This new role will also allow us to provide additional resources to our clients throughout the United States."

About MicroConstants, Inc. MicroConstants is a GLP-compliant Contract Research Organization (CRO) focused on performing regulated bioanalysis, drug metabolism and pharmacokinetic analysis to support discovery, preclinical and clinical drug development studies. They specialize in method development, method validation and sample analysis of small molecules, proteins, peptides and metabolites using LC/MS/MS, HPLC/UV, and immunoassay techniques. For more information, please visit

SOURCE MicroConstants

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs